AGP Executive Report
Last update: 11 hours agoRare-disease AI in Boston: Boston Children’s Hospital, Harvard, and OpenAI report that OpenAI’s o3 Deep Research reanalyzed 376 previously unsolved pediatric cases and—after specialist review and lab confirmation—produced diagnoses in 18 cases, a 4.8% added diagnostic yield. Transplant diagnostics in Boston: CareDx showcased new real-world findings at the American Transplant Congress in Boston, expanding how dd-cfDNA tests like AlloSure may move from surveillance toward clinical endpoints. Healthcare wearables expand in Boston: WHOOP launched a membership subsidy for healthcare professionals, aiming to support clinicians with continuous recovery and health monitoring. Cancer immunotherapy collaboration: Voro Therapeutics and Alloy Therapeutics announced a strategic research partnership to develop next-generation masked T-cell engager therapies with improved tumor selectivity. EV policy watch: A Brookings scorecard finds Massachusetts among the top states for EV readiness after federal incentive pullbacks, while many others lag. Public health: A study links HPV vaccination to steep declines in cervical cancer deaths in England, and another analysis suggests GLP-1 drugs may lower clot and death risk in people with autoimmune disease. Local tech policy: North Carolina cities, including Charlotte, are adopting temporary data center moratoriums amid electricity and water concerns.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
